Induction of autophagy and inhibition of melanoma growth in vitro and in vivo by hyperactivation of oncogenic BRAF

Journal of Investigative Dermatology

Volumn 130, Issue 6, 2010, Pages 1657-1667

  Maddodi, Nityanand ^a   Huang, Wei ^a   Havighurst, Thomas ^a   Kim, Kyungmann ^a   Longley, B Jack ^a   Setaluri, Vijayasaradhi ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; AUTOPHAGY; CANCER INHIBITION; CELL CYCLE ARREST; CELL DEATH; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALE; MELANOMA; MELANOMA CELL; MOUSE; NONHUMAN; ONCOGENE; PHENOTYPE; PRIORITY JOURNAL; SENESCENCE; TUMOR GROWTH; TUMOR NECROSIS;

ANIMALS; APOPTOSIS; AUTOPHAGY; CELL CYCLE; CELL LINE; CELL LINE, TUMOR; CELL PROLIFERATION; CELLS, CULTURED; FEMALE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MELANOMA; MICE; PLASMIDS; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS B-RAF; SIGNAL TRANSDUCTION; SKIN NEOPLASMS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 77952428054     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2010.26     Document Type: Article

References (43)

1. Braig M, Schmitt CA (2006) Oncogene-induced senescence: putting the brakes on tumor development. Cancer Res 66:2881-2884
2. Carswell EA, Old LJ, Kassel RL et al. (1975) An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA 72:3666-3670
3. Chen W, Kumar AR, Hudson WA et al. (2008) Malignant transformation initiated by Mll-AF9: gene dosage and critical target cells. Cancer Cell 13:432-440
4. Copp J, Manning G, Hunter T (2009) TORC-specific phosphorylation of mammalian target of rapamycin (mTOR): phospho-Ser2481 is a marker for intact mTOR signaling complex 2. Cancer Res 69:1821-1827
5. Corradetti MN, Guan KL (2006) Upstream of the mammalian target of rapamycin: do all roads pass through mTOR? Oncogene 25: 6347-6360
6. Courtois-Cox S, Williams SMG, Reczek EE et al. (2006) A negative feedback signaling network underlies oncogene-induced senescence. Cancer Cell 10:459-472
7. Dankort D, Curley DP, Cartlidge RA et al. (2009) BrafV600E cooperates with Pten loss to induce metastatic melanoma. Nature Genetics 41:544-552
8. Dankort D, Filenova E, Collado M et al. (2007) A new mouse model to explore the initiation, progression, and therapy of BRAFV600E-induced lung tumors. Genes Dev 21:379-384
9. Davies H, Bignell GR, Cox C et al. (2002) Mutations of the BRAF gene in human cancer. Nature 417:949-954
10. Demunter A, Stas M, Degreef H et al. (2001) Analysis of N-and K-Ras mutations in the distinctive tumor progression phases of melanoma. J Invest Dermatol 117:1483-1489
11. Dumaz N, Hayward R, Martin J et al. (2006) In melanoma, RAS mutations are accompanied by switching signaling from BRAF to CRAF and disrupted cyclic AMP signaling. Cancer Res 66:9483-9491
12. Eisen T, Ahmad T, Flaherty KT et al. (2006) Sorafenib in advanced melanoma: a Phase II randomised discontinuation trial analysis. Br J Cancer 95:581-586
13. Fang D, Hallman J, Sangha N et al. (2001) Expression of microtubule-associated protein 2 in benign and malignant melanocytes: implications for differentiation and progression of cutaneous melanoma. Am J Pathol 158:2107-2115
14. Furuta S, Hidaka E, Ogata A et al. (2004) Ras is involved in the negative control of autophagy through the class I PI3-kinase. Oncogene 23:3898-3904
15. Galluzzi L, Morselli E, Vicencio JM et al. (2008) Life, death and burial: multifaceted impact of autophagy. Biochem Soc Trans 036:786-790
16. Hoeflich KP, Gray DC, Eby MT et al. (2006) Oncogenic BRAF is required for tumor growth and maintenance in melanoma models. Cancer Res 66:999-1006
17. Høyer-Hansen M, Jäättelä M (2008) Autophagy. An emerging target for cancer therapy. Autophagy 4:574-580
18. Kabeya Y, Mizushima N, Ueno T et al. (2000) LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J 19:5720-5728
19. Karbowniczek M, Cash T, Cheung M et al. (2004) Regulation of B-Raf kinase activity by tuberin and Rheb is mammalian target of rapamycin (mTOR)-independent. J Biol Chem 279:29930-29937
20. Karbowniczek M, Spittle CS, Morrison T et al. (2009) mTOR is activated in the majority of malignant melanomas. J Invest Dermatol 128:980-987
21. Karreth FA, DeNicola GM, Winter SP et al. (2009) C-Raf inhibits MAPK activation and transformation by B-RafV600E. Mol Cell 36:477-486
22. Long X, Lin Y, Ortiz-Vega S et al. (2005) Rheb binds and regulates the mTOR kinase. Curr Biol 15:702-713
23. Lum JJ, DeBerardinis RJ, Thompson CB (2005) Autophagy in metazoans: cell survival in the land of plenty. Nat Rev Mol Cell Biol 6:439-448
24. Maiuri MC, Tasdemir E, Criollo A et al. (2008) Control of autophagy by oncogenes and tumor suppressor genes. Cell Death Differ 16:87-93
25. Michaloglou C, Vredeveld LC, Soengas WMS et al. (2005) BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature 436:720-724
26. Murphy DJ, Junttila MR, Pouyet L et al. (2008) Distinct thresholds govern Myc's biological output in vivo. Cancer Cell 14:447-457
27. Pattingre S, Bauvy C, Codogno P (2003) Amino acids interfere with the ERK1/2-dependent control of macroautophagy by controlling the activation of Raf-1 in human colon cancer HT-29 cells. J Biol Chem 278: 16667-16674
28. Patton EE, Widlund HR, Kutok JL et al. (2005) BRAF mutations are sufficient to promote nevi formation and cooperate with p53 in the genesis of melanoma. Curr Biol 15:249-254
29. Petiot A, Ogier-Denis E, Blommaart EFC et al. (2000) Distinct classes of phosphatidylinositol 3-kinases are involved in signaling pathways that control macroautophagy in HT-29 cells. J Biol Chem 275: 992-998
30. Petti C, Molla A, Vegetti C et al. (2006) Coexpression of NRASQ61R and BRAFV600E in human melanoma cells activates senescence and increases susceptibility to cell-mediated cytotoxicity. Cancer Res 66: 6503-6511
31. Prieur A, Peeper DS (2008) Cellular senescence in vivo: a barrier to tumorigenesis. Curr Opin Cell Biol 20:150-155
32. Qu X, Yu J, Bhagat G et al. (2003) Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. J Clin Invest 112:1809-1820
33. Romanko MJ, Rothstein RP, Levison SW (2004) Neural stem cells in the subventricular zone are resilient to hypoxia/ischemia whereas progenitors are vulnerable. J Cerebral Blood Flow Metab 24:814-825
34. Sarkisian CJ, Keister BA, Stairs DB et al. (2007) Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigen-esis. Nat Cell Biol 9:493-505
35. Scott KL, Kabbarah O, Liang M-C et al. (2009) GOLPH3 modulates mTOR signalling and rapamycin sensitivity in cancer. Nature 459: 1085-1090
36. Sensi M, Nicolini G, Petti C et al. (2006) Mutually exclusive NRASQ61R and BRAFV600E mutations at the single-cell level in the same human melanoma. Oncogene 25:3357-3364
37. Serrano M, Lin AW, McCurrach ME et al. (1997) Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88:593-602
38. Solit DB, Garraway LA, Pratilas CA et al. (2006) BRAF mutation predicts sensitivity to MEK inhibition. Nature 439:358-362
39. Turcotte S, Chan DA, Sutphin PD et al. (2008) A molecule targeting VHL-deficient renal cell carcinoma that induces autophagy. Cancer Cell 14:90-102
40. Uribe P, Andrade L, Gonzalez S (2006) Lack of association between BRAF mutation and MAPK ERK activation in melanocytic nevi. J Invest Dermatol 126:161-166
41. Wajapeyee N, Serra RW, Zhu X et al. (2008) Oncogenic BRAF induces senescence and apoptosis through pathways mediated by the secreted protein IGFBP7. Cell 132:363-374
42. Warren M, Twohig M, Pier T et al. (2009) Protein expression of matriptase and its cognate inhibitor HAI-1 in human prostate cancer: a tissue microarray and automated quantitative analysis. Appl Immunohistochem Mol Morphol 17:23-30
43. Wellbrock C, Ogilvie L, Hedley D et al. (2004) V599EB-RAF is an oncogene in melanocytes. Cancer Res 64:2338-2342